Effects of the calcium channel blocker nifedipine on epiphyseal growth plate and bone turnover: a study in rabbit.
The potential effects of a calcium channel blocker (nifedipine) on epiphyseal growth plate and bone remodeling have been investigated in growing rabbits. The treated group received 6 mg/kg/day nifedipine twice daily by gavage for 10 weeks. An untreated group was used as control; with this dose, neither toxic effects nor decrease in the body weight have been observed. No modifications of blood phosphocalcic parameters have been found. In the treated group there is a significant lower cancellous bone volume, lower osteogenesis, shorter labeled perimeters, and lower mineral apposition rate than in the control group. Epiphyseal growth plate thickness is lower than in the untreated animals and considerable morphological changes are observed in the growth zone compared with the control group. A decrease in the growth of humerus length was found. In conclusion, nifedipine affects bone physiology, especially with consequences on bone growth. These effects appear to be quantitatively important, and there is the possibility of bone side effects on therapeutic use in humans, especially in young subjects.
Duriez
J
J
Institut de Recherche sur les Maladies du Squelette, Institut Calot, Berck Sur Mer, France.
Flautre
B
B
Blary
M C
MC
Hardouin
P
P
D000818:Animals; D016723:Bone Remodeling / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D006132:Growth Plate / Q000187:drug effects*; D009543:Nifedipine / Q000494:pharmacology*; D011817:Rabbits
D009543:Nifedipine